Healthcare provider profile · identity verified

Barbara C Joebstl, MD

Internal Medicine · PHILADELPHIA, PA · NPI 1194769919

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	328	98
Rosuvastatin Calcium	Rosuvastatin Calcium	260	82
Atorvastatin Calcium	Atorvastatin Calcium	251	79
Omeprazole	Omeprazole	185	61
Famotidine	Famotidine	180	63
Hydrochlorothiazide	Hydrochlorothiazide	152	49
Gabapentin	Gabapentin	139	50
Fluticasone Propionate	Fluticasone Propionate	113	45
Losartan Potassium	Losartan Potassium	107	32
Pantoprazole Sodium	Pantoprazole Sodium	107	38
Levothyroxine Sodium	Levothyroxine Sodium	95	28
Lisinopril	Lisinopril	81	24
Metformin Hcl Er	Metformin Hcl	81	21
Valsartan	Valsartan	77	20
Escitalopram Oxalate	Escitalopram Oxalate	76	20
Synthroid	Levothyroxine Sodium	76	17
Albuterol Sulfate Hfa	Albuterol Sulfate	74	30
Furosemide	Furosemide	69	23
Sertraline Hcl	Sertraline Hcl	68	23
Carvedilol	Carvedilol	64	17
Simvastatin	Simvastatin	61	16
Montelukast Sodium	Montelukast Sodium	58	15
Metoprolol Succinate	Metoprolol Succinate	52	20
Pravastatin Sodium	Pravastatin Sodium	52	13
Ezetimibe	Ezetimibe	47	19
Metformin Hcl	Metformin Hcl	47	15
Alendronate Sodium	Alendronate Sodium	40	11
Eliquis	Apixaban	39	12
Atenolol	Atenolol	38	12
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	11
Olmesartan Medoxomil	Olmesartan Medoxomil	32	11
Glimepiride	Glimepiride	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Mounjaro	Tirzepatide	27	suppressed
Prednisone	Prednisone	27	25
Tamsulosin Hcl	Tamsulosin Hcl	27	suppressed
Azithromycin	Azithromycin	25	24
Levofloxacin	Levofloxacin	25	24
Memantine Hcl	Memantine Hcl	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	21
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Methylprednisolone	Methylprednisolone	23	17
Amoxicillin	Amoxicillin	22	19
Mupirocin	Mupirocin	22	20
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Ibuprofen	Ibuprofen	19	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Leflunomide	Leflunomide	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	17
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Orencia Clickject	Abatacept	16	suppressed
Ramipril	Ramipril	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	15	suppressed
Cephalexin	Cephalexin	15	15
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Ketoconazole	Ketoconazole	15	12
Meloxicam	Meloxicam	15	suppressed
Baclofen	Baclofen	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Ozempic	Semaglutide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Alprazolam	Alprazolam	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Actemra Actpen	Tocilizumab	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed
Xeljanz	Tofacitinib Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error